Disclosure of more information in the opinions on applications for authorisation
24 Apr 2020
The quantities emitted in the environment of non-threshold substances (for example environmental endocrine disruptors, PBTs and vPvBs) and the release factors will now be published in the opinions on applications for authorisation. In case the confidentiality on the...
Completeness check of chemical safety reports postponed until October 2020
9 Apr 2020
Due to the ongoing COVID-19 pandemic and to help companies which may face difficulties, ECHA has postponed the manual completeness checks to chemical safety reports to October 2020. The remaining changes to the completeness check will take effect on submissions as of...
New year, new visual identity, new website!
15 Jan 2020
At the start of 2020, and to celebrate our 8 years of existence, we are proud to present the new visual identity of Equitox. Through this development, we wanted to reaffirm our values and our missions. Thus, the new logo, without making a clean sweep of the previous...
Endocrine disruptor, where we are?
15 Jan 2020
In 2002, the World Health Organization (WHO) proposed a definition of endocrine disruptors (EDs). An EP is an exogenous substance that alters the functions of the endocrine system with the result that adverse effects on the health of an organism, its offspring or its...
Endocrine disruptor assessment in the scope of the Biocidal Product Regulation: current situation
27 Mar 2019
Since the application of the new criteria on endocrine disruptor (ED) in the scope of the Biocidal Product Regulation (BPR- Reg 528/2012), the pressure is put on the ED-evaluation of the active substance and the co-formulants of the biocidal products. This situation...